PD-L1 confers primary resistance to EGFR-TKI in EGFR mutant non-small cell lung cancer via inducing EMT phenotype
Yubo Zhang(Soochow University), Jian Huang(Soochow University), T. Liu(Soochow University), Yuanyuan Zeng(Sichuan University), Jingfen Zhu(Soochow University), Zhenzhong Liu(North Sichuan Medical University), Wenwen Du(Indiana University Bloomington)
Cited by 1
Related Papers
Degradable Carbon Dots with Broad-Spectrum Antibacterial Activity
|ACS Applied Materials & Interfaces|2018|407
The EGFR pathway is involved in the regulation of PD-L1 expression via the IL-6/JAK/STAT3 signaling pathway in EGFR-mutated non-small cell lung cancer
|International Journal of Oncology|2016|385
Circular RNA hsa_circ_0008305 (circPTK2) inhibits TGF-β-induced epithelial-mesenchymal transition and metastasis by controlling TIF1γ in non-small cell lung cancer
|Molecular Cancer|2018|369
PD-L1 induced by IFN-γ from tumor-associated macrophages via the JAK/STAT3 and PI3K/AKT signaling pathways promoted progression of lung cancer
|International Journal of Clinical Oncology|2017|315
JAK/STAT3 signaling is required for TGF-β-induced epithelial-mesenchymal transition in lung cancer cells
|International Journal of Oncology|2014|314